InvVax
Los Angeles
About InvVax
InvVax is a vaccine development company with a proprietary platform building breakthrough vaccines. Our initial product is a universal influenza vaccine.
Company Facts
- Operating status: Active
- Company type: For Profit
- IPO status: Private
- Employees: 1 – 10
- Estimated revenue: Less than $1M
- Total funding: $255.9K
- Funding stage: Seed
- Last round: Grant (Feb 2022)
- Website: inv-vax.com
- Phone: [email protected]
Industries & Categories
Biotechnology, Health Care
Social Profiles
Canonical: https://fsome.com/organization/invvax-123488 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.